|
|
|
|
|
非在研适应症- |
最高研发阶段临床2期 |
首次获批国家/地区- |
首次获批日期- |
Phase II, Open-label, Prospective, Single-arm, Single-center Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
The objective of the study is to assess the safety and efficacy of treatment with hypothyroxinemia adjunct to conventional therapies in GBM patients.
100 项与 Musli Thyropeutics Ltd. 相关的临床结果
0 项与 Musli Thyropeutics Ltd. 相关的专利(医药)
100 项与 Musli Thyropeutics Ltd. 相关的药物交易
100 项与 Musli Thyropeutics Ltd. 相关的转化医学